\-\ Texto\\:\\ \ \(0\)\
\-\ serum\ \(83\)\
\-\ ca\\ 27\\-29\\ \\ \\ \\ \\ \\ \\ 41\\ \\ h\\ \\ \\ \\(0\\-37\\)\\ u\\/ml\ \(0\)\
\-\ ca\\ 15\\-3\\ \\ \\ \\ \\ \\ \\ \\ 29\\ \\ \\ \\ \\ \\ \\ \\(0\\-32\\)\\ u\\/ml\ \(0\)\
\-\ pet\\:\ \(0\)\
\-\ an\\ irregular\\ region\\ of\\ uptake\\ about\\ the\\ junction\\ of\\ the\\ upper\\ and\\ lower\\ outer\\ quadrants\\ of\\ the\\ left\\ breast\\ has\\ a\\ maximum\\ suv\\ of\\ 5\\.3\\,\\ compatible\\ with\\ the\\ clinical\\ history\\ of\\ primary\\ inflammatory\\ carcinoma\\ of\\ the\\ breast\\.\\ two\\ foci\\ about\\ the\\ upper\\ outer\\ quadrant\\ \\/\\ axillary\\ tail\\ \\/\\ lower\\ axillary\\ lymph\\ node\\ region\\ of\\ the\\ left\\ breast\\ have\\ maximum\\ suvs\\ of\\ 2\\.8\\ and\\ 2\\.3\\.\\ \\ a\\ nodule\\ in\\ the\\ upper\\ axillary\\ region\\ has\\ a\\ maximum\\ suv\\ of\\ 2\\.0\\.\\ \\ an\\ approximately\\ one\\ cm\\ nodule\\ at\\ the\\ anteroinferior\\ aspect\\ of\\ the\\ liver\\ about\\ the\\ mid\\ clavicular\\ line\\ with\\ an\\ suv\\ of\\ 3\\.7\\ appears\\ to\\ correspond\\ with\\ the\\ description\\ of\\ the\\ recently\\ ct\\-detected\\ lesion\\.\\ \\ no\\ abnormal\\ uptake\\ is\\ identified\\ within\\ the\\ lungs\\ or\\ other\\ extrahepatic\\ tissues\\ to\\ suggest\\ specifically\\ metastatic\\ disease\\.\\ \\ physiologic\\ uptake\\ is\\ present\\ at\\ the\\ brain\\,\\ heart\\,\\ kidneys\\,\ \(0\)\
\-\ bladder\\,\\ skeletal\\ and\\ smooth\\ muscles\\.\ \(1\)\
\-\ impression\\:\ \(2\)\
\-\ 1\\.\\ primary\\ neoplasm\\ at\\ the\\ left\\ breast\\ with\\ possible\\ satellite\\ lesions\\,\\ lymph\\ node\\ metastases\\ or\\ reactive\\ lymph\\ nodes\\ about\\ axillary\\ tail\\ region\\.\ \(0\)\
\-\ 2\\.\\ nodal\\ uptake\\ at\\ axillary\\ region\\ with\\ minimal\\ hypermetabolism\\,\\ favor\\ reactive\\ lymph\\ node\\,\\ but\\ metastatic\\ disease\\ is\\ possible\\.\ \(0\)\
\-\ 3\\.\\ focal\\ hypermetabolic\\ lesion\\ of\\ liver\\ correlating\\ with\\ ct\\ abnormality\\,\\ suspicious\\ for\\ metastatic\\ disease\\.\ \(0\)\
\-\ u\\/s\\:\ \(0\)\
\-\ a\\ solid\\ 2\\.5\\ cm\\ hypoechoic\\ mass\\ at\\ the\\ anterior\\ aspect\\ of\\ the\\ medial\\ segment\\ of\\ the\\ left\\ lobe\\ of\\ the\\ liver\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ metastatic\\ invasive\\ ductal\\ carcinoma\\ \ \(0\)\
\-\ primary\\ liver\\ tumor\\ or\\ infection\ \(0\)\
\-\ patient\\ with\\ known\\ sever\\ fibrocystic\\ breast\\ diseases\\/p\\ several\\ aspirations\\,\\ now\\ with\\ 6\\ cm\\ firm\\ tender\ \(0\)\
\-\ inflamed\\ mass\\ lateral\\ left\\ breast\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ axillary\\:\\ 0\\.08029638674863081\ \(0\)\
\-\ breast\\:\\ 0\\.0654510299757208\ \(0\)\
\-\ suv\\:\\ 0\\.06094546136470648\ \(0\)\
\-\ maximum\\:\\ 0\\.0527112332769875\ \(0\)\
\-\ lymph\\:\\ 0\\.047744531611690615\ \(0\)\
\-\ uptake\\:\\ 0\\.04698938996116557\ \(0\)\
\-\ u\\/ml\\:\\ 0\\.04661644901236445\ \(0\)\
\-\ about\\:\\ 0\\.04559249143396889\ \(0\)\
\-\ region\\:\\ 0\\.04175780669964209\ \(0\)\
\-\ liver\\:\\ 0\\.04077815239906884\ \(0\)\
\-\ node\\:\\ 0\\.04059076448645054\ \(0\)\
\-\ tail\\:\\ 0\\.03255809383939922\ \(0\)\
\-\ outer\\:\\ 0\\.03141074259481275\ \(0\)\
\-\ 0\\-32\\:\\ 0\\.030503523958361586\ \(0\)\
\-\ ct\\-detected\\:\\ 0\\.030503523958361586\ \(0\)\
\-\ diseases\\/p\\:\\ 0\\.030503523958361586\ \(0\)\
\-\ metastatic\\:\\ 0\\.02977314053447876\ \(0\)\
\-\ \\/\\:\\ 0\\.029206910545549542\ \(0\)\
\-\ 15\\-3\\:\\ 0\\.02810509080763513\ \(0\)\
\-\ 2\\.3\\.\\:\\ 0\\.02810509080763513\ \(0\)\
\-\ aspirations\\:\\ 0\\.02810509080763513\ \(0\)\
\-\ reactive\\:\\ 0\\.027991929408310266\ \(0\)\
\-\ ductal\\:\\ 0\\.02787561717082666\ \(0\)\
\-\ ca\\:\\ 0\\.027537968975882496\ \(0\)\
\-\ hypermetabolism\\:\\ 0\\.026702097353973664\ \(0\)\
\-\ primary\\:\\ 0\\.0262773452895747\ \(0\)\
\-\ 27\\-29\\:\\ 0\\.025706657656908678\ \(0\)\
\-\ 0\\-37\\:\\ 0\\.025706657656908678\ \(0\)\
\-\ suvs\\:\\ 0\\.025706657656908678\ \(0\)\
\-\ sever\\:\\ 0\\.025706657656908678\ \(0\)\
\-\ carcinoma\\:\\ 0\\.025141117681825604\ \(0\)\
\-\ 2\\.0\\.\\:\\ 0\\.024934534641980616\ \(0\)\
\-\ nodule\\:\\ 0\\.024375180617591738\ \(0\)\
\-\ anteroinferior\\:\\ 0\\.024303664203247206\ \(0\)\
\-\ cm\\:\\ 0\\.023791932018861442\ \(0\)\
\-\ satellite\\:\\ 0\\.023770270847443545\ \(0\)\
\-\ 5\\.3\\:\\ 0\\.022206308481550616\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.022206308481550616\ \(0\)\
\-\ clavicular\\:\\ 0\\.021905231052520752\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.021905231052520752\ \(0\)\
\-\ correlating\\:\\ 0\\.02162826666610713\ \(0\)\
\-\ upper\\:\\ 0\\.021405679986526486\ \(0\)\
\-\ correspond\\:\\ 0\\.02113310803759269\ \(0\)\
\-\ 3\\.7\\:\\ 0\\.02090979135545577\ \(0\)\
\-\ u\\/s\\:\\ 0\\.02090979135545577\ \(0\)\
\-\ inflamed\\:\\ 0\\.020502237598859288\ \(0\)\
\-\ favor\\:\\ 0\\.020315153788235497\ \(0\)\
\-\ 2\\.8\\:\\ 0\\.020137668340527708\ \(0\)\
\-\ at\\:\\ 0\\.02003050437424971\ \(0\)\
\-\ quadrants\\:\\ 0\\.019968844243055624\ \(0\)\
\-\ physiologic\\:\\ 0\\.019968844243055624\ \(0\)\
\-\ possible\\:\\ 0\\.019916831964595656\ \(0\)\
\-\ nodal\\:\\ 0\\.019807875330824162\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.0195067979017943\ \(0\)\
\-\ description\\:\\ 0\\.019229833515380677\ \(0\)\
\-\ aspect\\:\\ 0\\.018576414771511125\ \(0\)\
\-\ specifically\\:\\ 0\\.016574971395264183\ \(0\)\
\-\ left\\:\\ 0\\.01654161365524074\ \(0\)\
\-\ compatible\\:\\ 0\\.016336241736139786\ \(0\)\
\-\ infiltrating\\:\\ 0\\.01605927734972616\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.016006448726436237\ \(0\)\
\-\ impression\\:\\ 0\\.01580284838033612\ \(0\)\
\-\ 41\\:\\ 0\\.015753766598357033\ \(0\)\
\-\ h\\:\\ 0\\.015564118721211724\ \(0\)\
\-\ pet\\:\\ 0\\.015518287486782587\ \(0\)\
\-\ 29\\:\\ 0\\.015428406910992757\ \(0\)\
\-\ invasive\\:\\ 0\\.014857196702136533\ \(0\)\
\-\ skeletal\\:\\ 0\\.014603455272774771\ \(0\)\
\-\ firm\\:\\ 0\\.014500157822429851\ \(0\)\
\-\ disease\\:\\ 0\\.014499005618156098\ \(0\)\
\-\ serum\\:\\ 0\\.014270486303589463\ \(0\)\
\-\ suspicious\\:\\ 0\\.01423888601444319\ \(0\)\
\-\ recently\\:\\ 0\\.013796556009218676\ \(0\)\
\-\ kidneys\\:\\ 0\\.013608015575709783\ \(0\)\
\-\ muscles\\:\\ 0\\.013504718125364867\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.013479368505669113\ \(0\)\
\-\ nodes\\:\\ 0\\.01335533344763058\ \(0\)\
\-\ lower\\:\\ 0\\.01330008352500943\ \(0\)\
\-\ smooth\\:\\ 0\\.012942368888348344\ \(0\)\
\-\ segment\\:\\ 0\\.012899384390083441\ \(0\)\
\-\ foci\\:\\ 0\\.012692124384612613\ \(0\)\
\-\ metastases\\:\\ 0\\.012632292214681607\ \(0\)\
\-\ suggest\\:\\ 0\\.012592971250493665\ \(0\)\
\-\ junction\\:\\ 0\\.012384347616389443\ \(0\)\
\-\ mid\\:\\ 0\\.012365991034279778\ \(0\)\
\-\ an\\:\\ 0\\.012266417276312074\ \(0\)\
\-\ line\\:\\ 0\\.012152987944316341\ \(0\)\
\-\ tissues\\:\\ 0\\.012135815662855686\ \(0\)\
\-\ lesion\\:\\ 0\\.012045364885816295\ \(0\)\
\-\ bladder\\:\\ 0\\.0120014217759482\ \(0\)\
\-\ tender\\:\\ 0\\.0120014217759482\ \(0\)\
\-\ irregular\\:\\ 0\\.011793587032894046\ \(0\)\
\-\ solid\\:\\ 0\\.011793587032894046\ \(0\)\
\-\ \\:\\:\\ 0\\.011732956567377145\ \(0\)\
\-\ minimal\\:\\ 0\\.011641799205539092\ \(0\)\
\-\ lungs\\:\\ 0\\.011196500339032097\ \(0\)\
\-\ has\\:\\ 0\\.011105190107226838\ \(0\)\
\-\ appears\\:\\ 0\\.011005982078883213\ \(0\)\
\-\ abnormality\\:\\ 0\\.010908504995953468\ \(0\)\
\-\ identified\\:\\ 0\\.01056562990029869\ \(0\)\
\-\ quadrant\\:\\ 0\\.010406145100297767\ \(0\)\
\-\ or\\:\\ 0\\.010396429920038485\ \(0\)\
\-\ heart\\:\\ 0\\.010273632003144547\ \(0\)\
\-\ inflammatory\\:\\ 0\\.010253688388207696\ \(0\)\
\-\ 3\\.\\:\\ 0\\.01011721180671532\ \(0\)\
\-\ now\\:\\ 0\\.010107666400351722\ \(0\)\
\-\ neoplasm\\:\\ 0\\.010069745937411516\ \(0\)\
\-\ the\\:\\ 0\\.009567424546963724\ \(0\)\
\-\ several\\:\\ 0\\.009505511542291999\ \(0\)\
\-\ medial\\:\\ 0\\.009457783784048624\ \(0\)\
\-\ 2\\.\\:\\ 0\\.009402920905883247\ \(0\)\
\-\ \\,\\:\\ 0\\.009367130294715828\ \(0\)\
\-\ known\\:\\ 0\\.009356578146933633\ \(0\)\
\-\ 1\\.\\:\\ 0\\.009235948672310038\ \(0\)\
\-\ approximately\\:\\ 0\\.009148158569396481\ \(0\)\
\-\ clinical\\:\\ 0\\.009097957785695516\ \(0\)\
\-\ brain\\:\\ 0\\.008897410115234471\ \(0\)\
\-\ 6\\:\\ 0\\.008830865610293682\ \(0\)\
\-\ infection\\:\\ 0\\.008595213059075457\ \(0\)\
\-\ two\\:\\ 0\\.008468274178602096\ \(0\)\
\-\ focal\\:\\ 0\\.008444614547191703\ \(0\)\
\-\ abnormal\\:\\ 0\\.008432845122196926\ \(0\)\
\-\ mass\\:\\ 0\\.008224643646695949\ \(0\)\
\-\ one\\:\\ 0\\.008012911360936485\ \(0\)\
\-\ lobe\\:\\ 0\\.007956143072399773\ \(0\)\
\-\ lesions\\:\\ 0\\.00791543427800674\ \(0\)\
\-\ anterior\\:\\ 0\\.007615200082224005\ \(0\)\
\-\ tumor\\:\\ 0\\.006893537375815956\ \(0\)\
\-\ other\\:\\ 0\\.006815358300008473\ \(0\)\
\-\ present\\:\\ 0\\.006678230982462564\ \(0\)\
\-\ of\\:\\ 0\\.0064500374144215045\ \(0\)\
\-\ have\\:\\ 0\\.006402899925138726\ \(0\)\
\-\ lateral\\:\\ 0\\.006389854829150694\ \(0\)\
\-\ but\\:\\ 0\\.006306239795963798\ \(0\)\
\-\ is\\:\\ 0\\.005836928495343173\ \(0\)\
\-\ within\\:\\ 0\\.005640593108602359\ \(0\)\
\-\ a\\:\\ 0\\.005489270613406246\ \(0\)\
\-\ \\(\\:\\ 0\\.004999043088192806\ \(0\)\
\-\ \\)\\:\\ 0\\.004937977108050554\ \(0\)\
\-\ ct\\:\\ 0\\.004135998800664509\ \(0\)\
\-\ history\\:\\ 0\\.004083787327706171\ \(0\)\
\-\ with\\:\\ 0\\.0032388699263637298\ \(0\)\
\-\ no\\:\\ 0\\.0029773154003591763\ \(0\)\
\-\ patient\\:\\ 0\\.00296398592012591\ \(0\)\
\-\ to\\:\\ 0\\.0029554886397438495\ \(0\)\
\-\ for\\:\\ 0\\.0025228655662377685\ \(0\)\
\-\ and\\:\\ 0\\.0018686055958361777\ \(0\)\
\-\ in\\:\\ 0\\.0014581219035994981\ \(0\)\
\-\ \\.\\:\\ 0\\.001105521885384486\ \(0\)\
